Telling Familiar Stories Can Help Brain Injury.
Hearing their loved ones carry weight overfree stories can help brain injury patients in a coma regain consciousness faster and have a better recovery, a restored study suggests. The study included 15 masculine and female brain injury patients, average age 35, who were in a vegetative or minimally alert state. Their brain injuries were caused by car or motorcycle crashes, blow up blasts or assaults. Beginning an average of 70 days after they suffered their brain injury, the patients were played recordings of their kindred members telling familiar stories that were stored in the patients' long-term memories.
The recordings were played over headphones four times a epoch for six weeks, according to the turn over published Jan. 22 in the journal Neurorehabilitation and Neural Repair. "We believe hearing those stories in parents' and siblings' voices exercises the circuits in the perceptiveness responsible for long-term memories," haunt author Theresa Pape, a neuroscientist in physical medicine and rehabilitation at Northwestern University's School of Medicine in Chicago, said in a university copy release.
Showing posts with label patients. Show all posts
Showing posts with label patients. Show all posts
Friday 5 July 2019
Wednesday 3 July 2019
Vitamin D And Chemotherapy Of Colon Cancer
Vitamin D And Chemotherapy Of Colon Cancer.
Higher vitamin D levels in patients with advanced colon cancer appear to benefit reply to chemotherapy and targeted anti-cancer drugs, researchers say. "We found that patients who had vitamin D levels at the highest department had improved survival and improved progression-free survival, compared with patients in the lowest category," said superintend inventor Dr Kimmie Ng, an assistant professor of medicine at Harvard Medical School in Boston. Those patients survived one-third longer than patients with ribald levels of vitamin D - an norm 32,6 months, compared with 24,5 months, the researchers found.
The report, scheduled for spectacle this week at the Gastrointestinal Cancers Symposium in San Francisco, adds more burden to suspicions that vitamin D might be a valuable cancer-fighting supplement. However, colon cancer patients shouldn't analyse to boost vitamin D levels beyond the usual range, one expert said. The study only found an association between vitamin D levels and colon cancer survival rates. It did not examine cause and effect.
Researchers for years have investigated vitamin D as a passive anti-cancer tool, but none of the findings have been strong enough to warrant a recommendation, said Dr Len Lichtenfeld, emissary chief medical officer for the American Cancer Society. "Everyone comes to the same conclusion - yes, there may be some benefit, but we at bottom need to study it carefully so we can be certain there aren't other factors that mutate vitamin D look better than it is.
These findings are interesting, and show that vitamin D may have a lines in improving outcomes in cancer care". In this study, researchers measured blood levels of vitamin D in 1,043 patients enrolled in a appearance 3 clinical attempt comparing three first-line treatments for newly diagnosed, advanced colon cancer. All of the treatments implicated chemotherapy combined with the targeted anti-cancer drugs bevacizumab and/or cetuximab.
Vitamin D is called the "sunshine vitamin" because kind-hearted bodies produce it when the sun's ultraviolet rays whip the skin. It promotes the intestines' ability to absorb calcium and other important minerals, and is fundamental for maintaining strong, healthy bones, according to the US National Institutes of Health. But vitamin D also influences cellular occupation in ways that could be beneficial in treating cancer.
Higher vitamin D levels in patients with advanced colon cancer appear to benefit reply to chemotherapy and targeted anti-cancer drugs, researchers say. "We found that patients who had vitamin D levels at the highest department had improved survival and improved progression-free survival, compared with patients in the lowest category," said superintend inventor Dr Kimmie Ng, an assistant professor of medicine at Harvard Medical School in Boston. Those patients survived one-third longer than patients with ribald levels of vitamin D - an norm 32,6 months, compared with 24,5 months, the researchers found.
The report, scheduled for spectacle this week at the Gastrointestinal Cancers Symposium in San Francisco, adds more burden to suspicions that vitamin D might be a valuable cancer-fighting supplement. However, colon cancer patients shouldn't analyse to boost vitamin D levels beyond the usual range, one expert said. The study only found an association between vitamin D levels and colon cancer survival rates. It did not examine cause and effect.
Researchers for years have investigated vitamin D as a passive anti-cancer tool, but none of the findings have been strong enough to warrant a recommendation, said Dr Len Lichtenfeld, emissary chief medical officer for the American Cancer Society. "Everyone comes to the same conclusion - yes, there may be some benefit, but we at bottom need to study it carefully so we can be certain there aren't other factors that mutate vitamin D look better than it is.
These findings are interesting, and show that vitamin D may have a lines in improving outcomes in cancer care". In this study, researchers measured blood levels of vitamin D in 1,043 patients enrolled in a appearance 3 clinical attempt comparing three first-line treatments for newly diagnosed, advanced colon cancer. All of the treatments implicated chemotherapy combined with the targeted anti-cancer drugs bevacizumab and/or cetuximab.
Vitamin D is called the "sunshine vitamin" because kind-hearted bodies produce it when the sun's ultraviolet rays whip the skin. It promotes the intestines' ability to absorb calcium and other important minerals, and is fundamental for maintaining strong, healthy bones, according to the US National Institutes of Health. But vitamin D also influences cellular occupation in ways that could be beneficial in treating cancer.
Saturday 29 June 2019
July Effect For Stroke Patients
July Effect For Stroke Patients.
People who diminish strokes in July - the month when medical trainees lead their hospital work - don't get on any worse than stroke patients treated the rest of the year, a new study finds. Researchers investigating the professed "July effect" found that when recent medical school graduates begin their residency programs every summer in teaching hospitals, this change doesn't reduce the quality of care for patients with compelling medical conditions, such as stroke. "We found there was no higher rate of deaths after 30 or 90 days, no poorer or greater rates of impotence or loss of independence and no evidence of a July effect for hint patients," said the study's lead author, Dr Gustavo Saposnik, director of the Stroke Research Center of St Michael's Hospital, Toronto, in a dispensary news release.
For the study, published recently in the Journal of Stroke and Cerebrovascular Diseases, the researchers examined records on more than 10300 patients who had an ischemic pet (stroke caused by a blood clot) between July 2003 and March 2008. They also analyzed term of hospitalization, referrals to long-term concern facilities and impecuniousness for readmission or emergency room treatment for a stroke or any other reason in the month after their discharge.
People who diminish strokes in July - the month when medical trainees lead their hospital work - don't get on any worse than stroke patients treated the rest of the year, a new study finds. Researchers investigating the professed "July effect" found that when recent medical school graduates begin their residency programs every summer in teaching hospitals, this change doesn't reduce the quality of care for patients with compelling medical conditions, such as stroke. "We found there was no higher rate of deaths after 30 or 90 days, no poorer or greater rates of impotence or loss of independence and no evidence of a July effect for hint patients," said the study's lead author, Dr Gustavo Saposnik, director of the Stroke Research Center of St Michael's Hospital, Toronto, in a dispensary news release.
For the study, published recently in the Journal of Stroke and Cerebrovascular Diseases, the researchers examined records on more than 10300 patients who had an ischemic pet (stroke caused by a blood clot) between July 2003 and March 2008. They also analyzed term of hospitalization, referrals to long-term concern facilities and impecuniousness for readmission or emergency room treatment for a stroke or any other reason in the month after their discharge.
New Gene Mutations Linked To Colon Cancer
New Gene Mutations Linked To Colon Cancer.
Researchers who discovered novel gene mutations linked to colon cancer in dark-skinned Americans say their findings could primacy to improved diagnosis and treatment. In the United States, blacks are significantly more likely to result colon cancer and to die from the disease than other racial groups. For the study, the researchers said they employed DNA sequencing to examined 50 million bits of data from 20000 genes. They said that determining gene mutations has been the driving persistence behind all the new drugs created to handle cancer in the last decade.
So "Many of the new cancer drugs on the market today were developed to object specific genes in which mutations were discovered to cause specific cancers," study corresponding initiator Dr Sanford Markowitz, an expert in the genetics of cancer at Case Western Reserve University in Cleveland, said in a university info release. The investigators compared 103 colon cancer samples from unspeakable patients and 129 samples from white patients treated at University Hospitals Case Medical Center in Cleveland.
Researchers who discovered novel gene mutations linked to colon cancer in dark-skinned Americans say their findings could primacy to improved diagnosis and treatment. In the United States, blacks are significantly more likely to result colon cancer and to die from the disease than other racial groups. For the study, the researchers said they employed DNA sequencing to examined 50 million bits of data from 20000 genes. They said that determining gene mutations has been the driving persistence behind all the new drugs created to handle cancer in the last decade.
So "Many of the new cancer drugs on the market today were developed to object specific genes in which mutations were discovered to cause specific cancers," study corresponding initiator Dr Sanford Markowitz, an expert in the genetics of cancer at Case Western Reserve University in Cleveland, said in a university info release. The investigators compared 103 colon cancer samples from unspeakable patients and 129 samples from white patients treated at University Hospitals Case Medical Center in Cleveland.
Wednesday 26 June 2019
How To Use Herbs And Supplements Wisely
How To Use Herbs And Supplements Wisely.
Despite concerns about potentially rickety interactions between cancer treatments and herbs and other supplements, most cancer doctors don't jibber-jabber to their patients about these products, creative research found. Fewer than half of cancer doctors - oncologists - deliver up the subject of herbs or supplements with their patients, the researchers found. Many doctors cited their own scarcity of information as a major reason why they skip that conversation. "Lack of information about herbs and supplements, and awareness of that lack of knowledge is probably one of the reasons why oncologists don't rookie the discussion," said the study's author, Dr Richard Lee, medical kingpin of the Integrative Medicine Program at the University of Texas MD Anderson Cancer Center in Houston.
And "It's at the end of the day about getting more research out there and more education so oncologists can feel comfortable having these conversations". The burn the midnight oil was published recently in the Journal of Clinical Oncology. People with cancer often bring over to herbs and other dietary supplements in an attempt to improve their health and cope with their symptoms, according to background dirt in the study. Although herbs and supplements are often viewed as "natural," they contain active ingredients that might cause deleterious interactions with standard cancer treatments.
Some supplements can cause skin reactions when taken by patients receiving dispersal treatment, according to the American Cancer Society (ACS). Herbs and supplements can also affect how chemotherapy drugs are lost and metabolized by the body, according to the ACS. St John's wort, Panax ginseng and environmental tea supplements are among those that can produce potentially dangerous interactions with chemotherapy, according to the study. For the in the know survey, the researchers asked almost 400 oncologists about their views and knowledge of supplements.
The general age of those who responded was 48 years. About three-quarters of them were men, and about three-quarters were white, the meditate on noted. The specialists polled talked about supplements with 41 percent of their patients. However, doctors initiated only 26 percent of these discussions, the researchers found. The look into also revealed that two out of three oncologists believed they didn't have enough poop about herbs and supplements to response their patients' questions.
Despite concerns about potentially rickety interactions between cancer treatments and herbs and other supplements, most cancer doctors don't jibber-jabber to their patients about these products, creative research found. Fewer than half of cancer doctors - oncologists - deliver up the subject of herbs or supplements with their patients, the researchers found. Many doctors cited their own scarcity of information as a major reason why they skip that conversation. "Lack of information about herbs and supplements, and awareness of that lack of knowledge is probably one of the reasons why oncologists don't rookie the discussion," said the study's author, Dr Richard Lee, medical kingpin of the Integrative Medicine Program at the University of Texas MD Anderson Cancer Center in Houston.
And "It's at the end of the day about getting more research out there and more education so oncologists can feel comfortable having these conversations". The burn the midnight oil was published recently in the Journal of Clinical Oncology. People with cancer often bring over to herbs and other dietary supplements in an attempt to improve their health and cope with their symptoms, according to background dirt in the study. Although herbs and supplements are often viewed as "natural," they contain active ingredients that might cause deleterious interactions with standard cancer treatments.
Some supplements can cause skin reactions when taken by patients receiving dispersal treatment, according to the American Cancer Society (ACS). Herbs and supplements can also affect how chemotherapy drugs are lost and metabolized by the body, according to the ACS. St John's wort, Panax ginseng and environmental tea supplements are among those that can produce potentially dangerous interactions with chemotherapy, according to the study. For the in the know survey, the researchers asked almost 400 oncologists about their views and knowledge of supplements.
The general age of those who responded was 48 years. About three-quarters of them were men, and about three-quarters were white, the meditate on noted. The specialists polled talked about supplements with 41 percent of their patients. However, doctors initiated only 26 percent of these discussions, the researchers found. The look into also revealed that two out of three oncologists believed they didn't have enough poop about herbs and supplements to response their patients' questions.
Thursday 20 June 2019
Small Crimes Elderly Can Mean Dementia
Small Crimes Elderly Can Mean Dementia.
Some older adults with dementia unwittingly sentence crimes similarly to theft or trespassing, and for a small number, it can be a senior sign of their mental decline, a new study finds. The behavior, researchers found, is most often seen in folk with a subtype of frontotemporal dementia. Frontotemporal dementia accounts for about 10 to 15 percent of all dementia cases, according to the Alzheimer's Association. Meanwhile, older adults with Alzheimer's - the most common forge of dementia - appear much less likely to show "criminal behavior," the researchers said. Still, almost 8 percent of Alzheimer's patients in the about had unintentionally committed some type of crime.
Most often, it was a conveyance violation, but there were some incidents of violence toward other people, researchers reported online Jan 5, 2015 in JAMA Neurology. Regardless of the fixed behavior, though, it should be seen as a consequence of a brain disease and not a crime. "I wouldn't put a appellation of 'criminal behavior' on what is really a manifestation of a brain disease," said Dr Mark Lachs, a geriatrics maestro who has studied aggressive behavior among dementia patients in nursing homes.
So "It's not surprising that some patients with dementing affliction would develop disinhibiting behaviors that can be construed as crook who is a professor of medicine at Weill Cornell Medical College in New York City. And it is high-ranking for families to be aware it can happen. The findings are based on records from nearly 2400 patients seen at the Memory and Aging Center at the University of California, San Francisco.
They included 545 populace with Alzheimer's and 171 with the behavioral varying of frontotemporal dementia, where public lose their normal impulse control. Dr Aaron Pinkhasov, chairman of behavioral healthfulness at Winthrop-University Hospital in Mineola, NY, explained that this type of dementia affects a brain jurisdiction - the frontal lobe - that "basically filters our thoughts and impulses before we put them out into the world".
Some older adults with dementia unwittingly sentence crimes similarly to theft or trespassing, and for a small number, it can be a senior sign of their mental decline, a new study finds. The behavior, researchers found, is most often seen in folk with a subtype of frontotemporal dementia. Frontotemporal dementia accounts for about 10 to 15 percent of all dementia cases, according to the Alzheimer's Association. Meanwhile, older adults with Alzheimer's - the most common forge of dementia - appear much less likely to show "criminal behavior," the researchers said. Still, almost 8 percent of Alzheimer's patients in the about had unintentionally committed some type of crime.
Most often, it was a conveyance violation, but there were some incidents of violence toward other people, researchers reported online Jan 5, 2015 in JAMA Neurology. Regardless of the fixed behavior, though, it should be seen as a consequence of a brain disease and not a crime. "I wouldn't put a appellation of 'criminal behavior' on what is really a manifestation of a brain disease," said Dr Mark Lachs, a geriatrics maestro who has studied aggressive behavior among dementia patients in nursing homes.
So "It's not surprising that some patients with dementing affliction would develop disinhibiting behaviors that can be construed as crook who is a professor of medicine at Weill Cornell Medical College in New York City. And it is high-ranking for families to be aware it can happen. The findings are based on records from nearly 2400 patients seen at the Memory and Aging Center at the University of California, San Francisco.
They included 545 populace with Alzheimer's and 171 with the behavioral varying of frontotemporal dementia, where public lose their normal impulse control. Dr Aaron Pinkhasov, chairman of behavioral healthfulness at Winthrop-University Hospital in Mineola, NY, explained that this type of dementia affects a brain jurisdiction - the frontal lobe - that "basically filters our thoughts and impulses before we put them out into the world".
Monday 17 June 2019
The Animal-Assisted Therapy
The Animal-Assisted Therapy.
People undergoing chemotherapy and emission for cancer may get an poignant lift from man's best friend, a new study suggests. The study, of patients with paramount and neck cancers, is among the first to scientifically test the effects of therapy dogs - trained and certified pooches brought in to effortlessness human anxiety, whether it's from trauma, maltreatment or illness. To dog lovers, it may be a no-brainer that canine companions bring comfort. And cure dogs are already a fixture in some US hospitals, as well as nursing homes, social service agencies, and other settings where rank and file are in need.
Dogs offer something that even the best-intentioned human caregiver can't very much match, said Rachel McPherson, executive director of the New York City-based Good Dog Foundation. "They give unconditional love," said McPherson, whose organizing trains and certifies treatment dogs for more than 350 facilities in New York, New Jersey, Connecticut and Massachusetts. "Dogs don't referee you, or try to give you advice, or tell you their stories," she pointed out.
Instead analysis dogs offer simple comfort to people facing scary circumstances, such as cancer treatment. But while that sounds good, doctors and hospitals on the side of scientific evidence. "We can weather for granted that supportive care for cancer patients, like a healthy diet, has benefits," said Dr Stewart Fleishman, the bring on researcher on the new study. "We wanted to as a matter of fact test animal-assisted therapy and quantify the effects". Fleishman, now retired, was founding governor of cancer supportive services at Beth Israel Medical Center in New York City - now called Mount Sinai Beth Israel.
For the novel study, his team followed 42 patients at the nursing home who were undergoing six weeks of chemotherapy and radiation for head and neck cancers, mostly affecting the bombast and throat. All of the patients agreed to have visits with a therapy dog honest before each of their treatment sessions. The dogs, trained by the Good Dog Foundation, were brought in to the waiting room, or convalescent home room, so patients could spend about 15 minutes with them.
People undergoing chemotherapy and emission for cancer may get an poignant lift from man's best friend, a new study suggests. The study, of patients with paramount and neck cancers, is among the first to scientifically test the effects of therapy dogs - trained and certified pooches brought in to effortlessness human anxiety, whether it's from trauma, maltreatment or illness. To dog lovers, it may be a no-brainer that canine companions bring comfort. And cure dogs are already a fixture in some US hospitals, as well as nursing homes, social service agencies, and other settings where rank and file are in need.
Dogs offer something that even the best-intentioned human caregiver can't very much match, said Rachel McPherson, executive director of the New York City-based Good Dog Foundation. "They give unconditional love," said McPherson, whose organizing trains and certifies treatment dogs for more than 350 facilities in New York, New Jersey, Connecticut and Massachusetts. "Dogs don't referee you, or try to give you advice, or tell you their stories," she pointed out.
Instead analysis dogs offer simple comfort to people facing scary circumstances, such as cancer treatment. But while that sounds good, doctors and hospitals on the side of scientific evidence. "We can weather for granted that supportive care for cancer patients, like a healthy diet, has benefits," said Dr Stewart Fleishman, the bring on researcher on the new study. "We wanted to as a matter of fact test animal-assisted therapy and quantify the effects". Fleishman, now retired, was founding governor of cancer supportive services at Beth Israel Medical Center in New York City - now called Mount Sinai Beth Israel.
For the novel study, his team followed 42 patients at the nursing home who were undergoing six weeks of chemotherapy and radiation for head and neck cancers, mostly affecting the bombast and throat. All of the patients agreed to have visits with a therapy dog honest before each of their treatment sessions. The dogs, trained by the Good Dog Foundation, were brought in to the waiting room, or convalescent home room, so patients could spend about 15 minutes with them.
Friday 14 June 2019
The Risk Of Dangerous Blood Clots And Strokes
The Risk Of Dangerous Blood Clots And Strokes.
A unusual anti-clotting treat to reduce the risk of dangerous blood clots and strokes in males and females with a type of heart rhythm disorder has been approved by the US Food and Drug Administration. Savaysa (edoxaban) is approved to pay for people with atrial fibrillation that's not caused by a heart valve problem. Atrial fibrillation - the most average type of heart rhythm disorder - increases the jeopardy of developing blood clots that can travel to the brain and cause a stroke.
Savaysa pills are also approved to expound deep vein thrombosis and pulmonary embolism in people already treated with an injected or infused anti-clotting cure for five to 10 days, according to the FDA. Deep vein thrombosis is a blood clot that forms in a involved vein, usually in the lower leg or thigh. Pulmonary embolism is a potentially wearisome condition that occurs when a deep vein blood clot breaks off and travels to an artery in the lungs, blocking blood flow.
A unusual anti-clotting treat to reduce the risk of dangerous blood clots and strokes in males and females with a type of heart rhythm disorder has been approved by the US Food and Drug Administration. Savaysa (edoxaban) is approved to pay for people with atrial fibrillation that's not caused by a heart valve problem. Atrial fibrillation - the most average type of heart rhythm disorder - increases the jeopardy of developing blood clots that can travel to the brain and cause a stroke.
Savaysa pills are also approved to expound deep vein thrombosis and pulmonary embolism in people already treated with an injected or infused anti-clotting cure for five to 10 days, according to the FDA. Deep vein thrombosis is a blood clot that forms in a involved vein, usually in the lower leg or thigh. Pulmonary embolism is a potentially wearisome condition that occurs when a deep vein blood clot breaks off and travels to an artery in the lungs, blocking blood flow.
Tuesday 11 June 2019
A Blood Transfusion And Coronary Artery Bypass Surgery
A Blood Transfusion And Coronary Artery Bypass Surgery.
Receiving a blood transfusion during soul sidestep surgery may raise a patient's risk of pneumonia, researchers report. "The power to store and transfuse blood is one of medicine's greatest accomplishments, but we are continuing to finance that receiving a blood transfusion may alter a patient's ability to fight infection," Dr James Edgerton, of The Heart Hospital, Baylor Plano in Texas, said in a Society of Thoracic Surgeons flash release. He was not convoluted in the study. For the current study, investigators looked at material on more than 16000 patients who had heart bypass surgery.
The surgeries took mission at 33 US hospitals between 2011 and 2013. Nearly 40 percent of those surgical patients received red blood chamber transfusions, the findings showed. Just under 4 percent of the uninterrupted group developed pneumonia. People given one or two units of red blood cells were twice as disposed to to develop pneumonia compared to those who didn't receive blood transfusions. Those who received six units or more were 14 times more suitable to develop pneumonia, the researchers found.
Receiving a blood transfusion during soul sidestep surgery may raise a patient's risk of pneumonia, researchers report. "The power to store and transfuse blood is one of medicine's greatest accomplishments, but we are continuing to finance that receiving a blood transfusion may alter a patient's ability to fight infection," Dr James Edgerton, of The Heart Hospital, Baylor Plano in Texas, said in a Society of Thoracic Surgeons flash release. He was not convoluted in the study. For the current study, investigators looked at material on more than 16000 patients who had heart bypass surgery.
The surgeries took mission at 33 US hospitals between 2011 and 2013. Nearly 40 percent of those surgical patients received red blood chamber transfusions, the findings showed. Just under 4 percent of the uninterrupted group developed pneumonia. People given one or two units of red blood cells were twice as disposed to to develop pneumonia compared to those who didn't receive blood transfusions. Those who received six units or more were 14 times more suitable to develop pneumonia, the researchers found.
Friday 31 May 2019
An Insurance Industry And Affordable Care Act
An Insurance Industry And Affordable Care Act.
Some guarantee companies may be using high-dollar pharmaceutics co-pays to flout the Affordable Care Act's (ACA) mandate against discernment on the basis of pre-existing health problems, Harvard researchers claim. These insurers may have structured their dose coverage to discourage people with HIV from enrolling in their plans through the health indemnification marketplaces created by the ACA, sometimes called "Obamacare," the researchers contend in the Jan 29, 2015 exit of the New England Journal of Medicine. The companies are placing all HIV medicines, including generics, in the highest cost-sharing variety of their drug coverage, a practice known as "adverse tiering," said outdo author Doug Jacobs, a medical student at the Harvard School of Public Health.
And "For someone with HIV, if they were in an adverse tiering plan, they would give on ordinary $3000 more a year to be in that plan". One out of every four health plans placed commonly in use HIV drugs at the highest level of co-insurance, requiring patients to pay 30 percent or more of the medicine's cost, according to the researchers' fly-past of 12 states' insurance marketplaces. "This is appalling. It's a shiny case of discrimination," said Greg Millett, vice president and pilot of public policy for amfAR, The Foundation for AIDS Research.
So "We've heard anecdotal reports about this regulate before, but this study shows a clear pattern of discrimination". However, the findings by description show that three out of four plans are offering HIV coverage at more reasonable rates, said Clare Krusing, captain of communications for America's Health Insurance Plans, an bond industry group. Patients with HIV can choose to move to one of those plans.
But "This report in effect misses that point, and I think that's the overarching component that is important to highlight. Consumers do have that choice, and that ideal is an important part of the marketplace". The Harvard researchers undertook their workroom after hearing of a formal complaint submitted to federal regulators in May, which contended that Florida insurers had structured their antidepressant coverage to discourage enrollment by HIV patients, according to background information in the paper.
They unwavering to analyze the drug pricing policies of 48 health plans offered through 12 states' surety marketplaces. The researchers focused on six states mentioned in the US Department of Health and Human Services (HHS) complaint: Delaware, Florida, Louisiana, Michigan, South Carolina and Utah. They also analyzed plans offered through the six most teeming states that did not have any insurers mentioned in the HHS complaint: Illinois, New Jersey, Ohio, Pennsylvania, Texas and Virginia.
Some guarantee companies may be using high-dollar pharmaceutics co-pays to flout the Affordable Care Act's (ACA) mandate against discernment on the basis of pre-existing health problems, Harvard researchers claim. These insurers may have structured their dose coverage to discourage people with HIV from enrolling in their plans through the health indemnification marketplaces created by the ACA, sometimes called "Obamacare," the researchers contend in the Jan 29, 2015 exit of the New England Journal of Medicine. The companies are placing all HIV medicines, including generics, in the highest cost-sharing variety of their drug coverage, a practice known as "adverse tiering," said outdo author Doug Jacobs, a medical student at the Harvard School of Public Health.
And "For someone with HIV, if they were in an adverse tiering plan, they would give on ordinary $3000 more a year to be in that plan". One out of every four health plans placed commonly in use HIV drugs at the highest level of co-insurance, requiring patients to pay 30 percent or more of the medicine's cost, according to the researchers' fly-past of 12 states' insurance marketplaces. "This is appalling. It's a shiny case of discrimination," said Greg Millett, vice president and pilot of public policy for amfAR, The Foundation for AIDS Research.
So "We've heard anecdotal reports about this regulate before, but this study shows a clear pattern of discrimination". However, the findings by description show that three out of four plans are offering HIV coverage at more reasonable rates, said Clare Krusing, captain of communications for America's Health Insurance Plans, an bond industry group. Patients with HIV can choose to move to one of those plans.
But "This report in effect misses that point, and I think that's the overarching component that is important to highlight. Consumers do have that choice, and that ideal is an important part of the marketplace". The Harvard researchers undertook their workroom after hearing of a formal complaint submitted to federal regulators in May, which contended that Florida insurers had structured their antidepressant coverage to discourage enrollment by HIV patients, according to background information in the paper.
They unwavering to analyze the drug pricing policies of 48 health plans offered through 12 states' surety marketplaces. The researchers focused on six states mentioned in the US Department of Health and Human Services (HHS) complaint: Delaware, Florida, Louisiana, Michigan, South Carolina and Utah. They also analyzed plans offered through the six most teeming states that did not have any insurers mentioned in the HHS complaint: Illinois, New Jersey, Ohio, Pennsylvania, Texas and Virginia.
Thursday 30 May 2019
The Risk Of Stroke And Aggressive Cancer
The Risk Of Stroke And Aggressive Cancer.
Newly diagnosed cancer patients are at increased jeopardy for rub in the months after they find out they have the disease. And the gamble of stroke is higher among those with more aggressive cancer, a new study says. The findings come from an judgement of Medicare claims submitted between 2001 and 2009 by patients aged 66 and older who had been diagnosed with breast, colorectal, lung, prostate and pancreatic cancer. Compared to cancer-free seniors, those with cancer had a much higher hazard of stroke.
And the danger was highest in the first three months after cancer diagnosis, when the concentration of chemotherapy, radiation and other treatments is typically highest, the researchers at Weill Cornell Medical College in New York City said in a college statement release. The imperil of stroke was highest among patients with lung, pancreatic and colorectal cancers, which are often diagnosed at advanced stages. Stroke peril was lowest among those with breast and prostate cancers, which are often diagnosed when patients have localized tumors, the researchers said.
Newly diagnosed cancer patients are at increased jeopardy for rub in the months after they find out they have the disease. And the gamble of stroke is higher among those with more aggressive cancer, a new study says. The findings come from an judgement of Medicare claims submitted between 2001 and 2009 by patients aged 66 and older who had been diagnosed with breast, colorectal, lung, prostate and pancreatic cancer. Compared to cancer-free seniors, those with cancer had a much higher hazard of stroke.
And the danger was highest in the first three months after cancer diagnosis, when the concentration of chemotherapy, radiation and other treatments is typically highest, the researchers at Weill Cornell Medical College in New York City said in a college statement release. The imperil of stroke was highest among patients with lung, pancreatic and colorectal cancers, which are often diagnosed at advanced stages. Stroke peril was lowest among those with breast and prostate cancers, which are often diagnosed when patients have localized tumors, the researchers said.
Monday 27 May 2019
Weight-Loss Surgery Can Prolong Life
Weight-Loss Surgery Can Prolong Life.
Weight-loss surgery appears to keep up way of life for severely obese adults, a new study of US veterans finds. Among 2500 stout adults who underwent so-called bariatric surgery, the death rate was about 14 percent after 10 years compared with almost 24 percent for plump patients who didn't have weight-loss surgery, researchers found. "Patients with burdensome obesity can have greater confidence that bariatric surgical procedures are associated with better long-term survival than not having surgery," said flex researcher Dr David Arterburn, an accomplice investigator with the Group Health Research Institute in Seattle. Earlier studies have shown better survival middle younger obese women who had weight-loss surgery, but this study confirms this pronouncement in older men and women who suffer from other health problems, such as diabetes and high blood pressure.
The findings were published Jan 6, 2015 in the Journal of the American Medical Association. "We were not able to influence in our exploration the reasons why veterans lived longer after surgery than they did without surgery. "However, other check out suggests that bariatric surgery reduces the risk of diabetes, heart disease and cancer, which may be the foremost ways that surgery prolongs life". Dr John Lipham, chief of northerly gastrointestinal and general surgery at the Keck School of Medicine at the University of Southern California, Los Angeles, said that patients who have weight-loss surgery most often see their diabetes disappear
And "This by itself is booming to provide a survival benefit. Shedding excess weight also lowers blood urge and cholesterol levels and reduces the odds of developing heart disease. "If you are obese and not able to lose weight on your own, bariatric surgery should be considered". Arterburn said most insurance plans including Medicare occupy bariatric surgery. As with any surgery, however, weight-loss surgery carries some risks.
Weight-loss surgery appears to keep up way of life for severely obese adults, a new study of US veterans finds. Among 2500 stout adults who underwent so-called bariatric surgery, the death rate was about 14 percent after 10 years compared with almost 24 percent for plump patients who didn't have weight-loss surgery, researchers found. "Patients with burdensome obesity can have greater confidence that bariatric surgical procedures are associated with better long-term survival than not having surgery," said flex researcher Dr David Arterburn, an accomplice investigator with the Group Health Research Institute in Seattle. Earlier studies have shown better survival middle younger obese women who had weight-loss surgery, but this study confirms this pronouncement in older men and women who suffer from other health problems, such as diabetes and high blood pressure.
The findings were published Jan 6, 2015 in the Journal of the American Medical Association. "We were not able to influence in our exploration the reasons why veterans lived longer after surgery than they did without surgery. "However, other check out suggests that bariatric surgery reduces the risk of diabetes, heart disease and cancer, which may be the foremost ways that surgery prolongs life". Dr John Lipham, chief of northerly gastrointestinal and general surgery at the Keck School of Medicine at the University of Southern California, Los Angeles, said that patients who have weight-loss surgery most often see their diabetes disappear
And "This by itself is booming to provide a survival benefit. Shedding excess weight also lowers blood urge and cholesterol levels and reduces the odds of developing heart disease. "If you are obese and not able to lose weight on your own, bariatric surgery should be considered". Arterburn said most insurance plans including Medicare occupy bariatric surgery. As with any surgery, however, weight-loss surgery carries some risks.
Tuesday 14 May 2019
Diabetes Medications And Cancer
Diabetes Medications And Cancer.
People with diabetes are less conceivable to take their diabetes medications if they've been diagnosed with cancer, researchers report. The green study included more than 16000 diabetes patients, undistinguished age 68, taking drugs to lower their blood sugar. Of those patients, more than 3200 were diagnosed with cancer. "This review revealed that the medication adherence among users of blood sugar-lowering drugs was influenced by cancer diagnosis," the researchers wrote. "Although the modify of cancer was more pronounced among cancers with a worse prognosis and among those with more advanced cancer stages, the reformation in prognosis associated with these cancers seemed to only partly explain the strike of cancer on medication adherence".
To determine the impact, the Dutch and Canadian researchers analyzed the patients' medication tenure ratio (MPR), which represents the amount of medication patients had in their possession over a unerring period of time. In this study, a 10 percent decline in MPR translated into three days a month where patients did not nick their diabetes medications. At the time of cancer diagnosis, there was an overall 6,3 percent exclude in MPR, followed by a 0,20 percent monthly decline following a cancer diagnosis.
People with diabetes are less conceivable to take their diabetes medications if they've been diagnosed with cancer, researchers report. The green study included more than 16000 diabetes patients, undistinguished age 68, taking drugs to lower their blood sugar. Of those patients, more than 3200 were diagnosed with cancer. "This review revealed that the medication adherence among users of blood sugar-lowering drugs was influenced by cancer diagnosis," the researchers wrote. "Although the modify of cancer was more pronounced among cancers with a worse prognosis and among those with more advanced cancer stages, the reformation in prognosis associated with these cancers seemed to only partly explain the strike of cancer on medication adherence".
To determine the impact, the Dutch and Canadian researchers analyzed the patients' medication tenure ratio (MPR), which represents the amount of medication patients had in their possession over a unerring period of time. In this study, a 10 percent decline in MPR translated into three days a month where patients did not nick their diabetes medications. At the time of cancer diagnosis, there was an overall 6,3 percent exclude in MPR, followed by a 0,20 percent monthly decline following a cancer diagnosis.
Friday 10 May 2019
The Earlier Courses Of Multiple Sclerosis
The Earlier Courses Of Multiple Sclerosis.
A cure that uses patients' own primordial blood cells may be able to reverse some of the effects of multiple sclerosis, a preparatory study suggests. The findings, published Tuesday in the Journal of the American Medical Association, had experts cautiously optimistic. But they also stressed that the office was small - with around 150 patients - and the benefits were minimal to people who were in the earlier courses of multiple sclerosis (MS). "This is certainly a persuasive development," said Bruce Bebo, the executive vice president of analyse for the National Multiple Sclerosis Society.
There are numerous so-called "disease-modifying" drugs available to premium MS - a disease in which the immune system mistakenly attacks the protective sheath (called myelin) around fibers in the perception and spine, according to the society. Depending on where the damage is, symptoms cover muscle weakness, numbness, vision problems and difficulty with balance and coordination. But while those drugs can ease up the progression of MS, they can't reverse disability, said Dr Richard Burt, the principal researcher on the new study and chief of immunotherapy and autoimmune diseases at Northwestern University's Feinberg School of Medicine in Chicago.
His tandem tested a new approach: essentially, "rebooting" the unsusceptible system with patients' own blood-forming stem cells - primitive cells that develop into immune-system fighters. The researchers removed and stored stem cells from MS patients' blood, then cast-off relatively low-dose chemotherapy drugs to - as Burt described it - "turn down" the patients' immune-system activity. From there, the stock cells were infused back into patients' blood.
Just over 80 males and females were followed for two years after they had the procedure, according to the study. Half catch-phrase their score on a standard MS disability scale fall by one point or more, according to Burt's team. Of 36 patients who were followed for four years, nearly two-thirds platitude that much of an improvement. Bebo said a one-point swop on that scale - called the Expanded Disability Status Scale - is meaningful. "It would patently improve patients' quality of life".
What's more, of the patients followed for four years, 80 percent remained liberate of a symptom flare-up. There are caveats, though. One is that the treatment was only effective for patients with relapsing-remitting MS - where symptoms broadening up, then improve or disappear for a period of time. It was not helpful for the 27 patients with secondary-progressive MS, or those who'd had any visualize of MS for more than 10 years.
A cure that uses patients' own primordial blood cells may be able to reverse some of the effects of multiple sclerosis, a preparatory study suggests. The findings, published Tuesday in the Journal of the American Medical Association, had experts cautiously optimistic. But they also stressed that the office was small - with around 150 patients - and the benefits were minimal to people who were in the earlier courses of multiple sclerosis (MS). "This is certainly a persuasive development," said Bruce Bebo, the executive vice president of analyse for the National Multiple Sclerosis Society.
There are numerous so-called "disease-modifying" drugs available to premium MS - a disease in which the immune system mistakenly attacks the protective sheath (called myelin) around fibers in the perception and spine, according to the society. Depending on where the damage is, symptoms cover muscle weakness, numbness, vision problems and difficulty with balance and coordination. But while those drugs can ease up the progression of MS, they can't reverse disability, said Dr Richard Burt, the principal researcher on the new study and chief of immunotherapy and autoimmune diseases at Northwestern University's Feinberg School of Medicine in Chicago.
His tandem tested a new approach: essentially, "rebooting" the unsusceptible system with patients' own blood-forming stem cells - primitive cells that develop into immune-system fighters. The researchers removed and stored stem cells from MS patients' blood, then cast-off relatively low-dose chemotherapy drugs to - as Burt described it - "turn down" the patients' immune-system activity. From there, the stock cells were infused back into patients' blood.
Just over 80 males and females were followed for two years after they had the procedure, according to the study. Half catch-phrase their score on a standard MS disability scale fall by one point or more, according to Burt's team. Of 36 patients who were followed for four years, nearly two-thirds platitude that much of an improvement. Bebo said a one-point swop on that scale - called the Expanded Disability Status Scale - is meaningful. "It would patently improve patients' quality of life".
What's more, of the patients followed for four years, 80 percent remained liberate of a symptom flare-up. There are caveats, though. One is that the treatment was only effective for patients with relapsing-remitting MS - where symptoms broadening up, then improve or disappear for a period of time. It was not helpful for the 27 patients with secondary-progressive MS, or those who'd had any visualize of MS for more than 10 years.
Saturday 4 May 2019
Flu Vaccination Is Needed For Cancer Patients
Flu Vaccination Is Needed For Cancer Patients.
People with cancer camouflage a higher gamble for serious flu-related complications, so getting vaccinated should be at the top of their to-do liber veritatis this winter, an expert says in Dec 2013. "The flu shot is recommended annually for cancer patients, as it is the most striking way to prevent influenza and its complications," Dr Mollie deShazo, an accomplice professor of medicine in the division of hematology and oncology at the University of Alabama at Birmingham, said in a scuttlebutt release. "The flu vaccine significantly lowers the risk of acquiring the flu.
It is not 100 percent effective, but it is the best gizmo we have". Pneumonia, bronchitis, sinus infections and ear infections are examples of flu-related complications, according to the US Centers for Disease Control and Prevention. It is recommended that anyone who has not done so already get a flu shot. Although this year's flu opportunity is off to a dull start nationally, the add of cases in the south-central United States is rapidly increasing, with five deaths already reported in Texas.
People with cancer camouflage a higher gamble for serious flu-related complications, so getting vaccinated should be at the top of their to-do liber veritatis this winter, an expert says in Dec 2013. "The flu shot is recommended annually for cancer patients, as it is the most striking way to prevent influenza and its complications," Dr Mollie deShazo, an accomplice professor of medicine in the division of hematology and oncology at the University of Alabama at Birmingham, said in a scuttlebutt release. "The flu vaccine significantly lowers the risk of acquiring the flu.
It is not 100 percent effective, but it is the best gizmo we have". Pneumonia, bronchitis, sinus infections and ear infections are examples of flu-related complications, according to the US Centers for Disease Control and Prevention. It is recommended that anyone who has not done so already get a flu shot. Although this year's flu opportunity is off to a dull start nationally, the add of cases in the south-central United States is rapidly increasing, with five deaths already reported in Texas.
Monday 22 April 2019
New Way To Treat Parkinson's Disease
New Way To Treat Parkinson's Disease.
Deep imagination stimulation might assistant improve the driving ability of people with Parkinson's disease, a new German analyse suggests. A deep brain stimulator is an implanted device that sends electrical impulses to the brain. With patients who have epilepsy, the stimulator is believed to shame the risk of seizures, the researchers said. A driving simulator tested the abilities of 23 Parkinson's patients with a wide perceptiveness stimulator, 21 patients without the device and a control group of 21 people without Parkinson's.
Deep imagination stimulation might assistant improve the driving ability of people with Parkinson's disease, a new German analyse suggests. A deep brain stimulator is an implanted device that sends electrical impulses to the brain. With patients who have epilepsy, the stimulator is believed to shame the risk of seizures, the researchers said. A driving simulator tested the abilities of 23 Parkinson's patients with a wide perceptiveness stimulator, 21 patients without the device and a control group of 21 people without Parkinson's.
Patients With Head And Neck Cancer Can Swallow And Speak After Therapy
Patients With Head And Neck Cancer Can Swallow And Speak After Therapy.
Most perception and neck cancer patients can communicate and accept after undergoing combined chemotherapy and radiation treatment, but several factors may be associated with poor outcomes, researchers have found. The late study included patients who were assessed nearly three years after they were successfully treated with chemoradiotherapy for advanced leadership and neck cancer. The US researchers gave a speaking make out of 1 through 4 to 163 patients an average of 34,8 months after they completed treatment, and gave a swallowing number of 1 through 4 to 166 patients an average of 34,5 months after treatment.
A higher nick indicated reduced ability to speak or swallow. Most of the patients (84,7 percent of those assigned speaking scores and 63,3 percent of those given swallowing scores) had no everlasting problems and received a cause of 1. Of the 160 patients who were given both speaking and swallowing scores, 96 had a amount of 1 in each category, the investigators found.
Most perception and neck cancer patients can communicate and accept after undergoing combined chemotherapy and radiation treatment, but several factors may be associated with poor outcomes, researchers have found. The late study included patients who were assessed nearly three years after they were successfully treated with chemoradiotherapy for advanced leadership and neck cancer. The US researchers gave a speaking make out of 1 through 4 to 163 patients an average of 34,8 months after they completed treatment, and gave a swallowing number of 1 through 4 to 166 patients an average of 34,5 months after treatment.
A higher nick indicated reduced ability to speak or swallow. Most of the patients (84,7 percent of those assigned speaking scores and 63,3 percent of those given swallowing scores) had no everlasting problems and received a cause of 1. Of the 160 patients who were given both speaking and swallowing scores, 96 had a amount of 1 in each category, the investigators found.
Friday 19 April 2019
For Patients With Severe Chronic Obstructive Pulmonary Disease, Low Dose Steroid Tablets May Be Better Than Large Doses Of Injections
For Patients With Severe Chronic Obstructive Pulmonary Disease, Low Dose Steroid Tablets May Be Better Than Large Doses Of Injections.
Low-dose steroid pills seem to opus as well as exorbitant doses of injected steroids for patients hospitalized with unembroidered long-lived obstructive pulmonary disease (COPD), researchers report. Yet, some 90 percent of these COPD patients are given the higher doses, which is inimical to current prescribing guidelines, claims the swot appearing in the June 16 issue of the Journal of the American Medical Association. "We honestly think that doctors should be following hospital guidelines and treating patients with oral steroids, at least for those who are able to misappropriate oral steroids," said Dr Richard Mularski, author of an accompanying leader and a pulmonologist with Kaiser Permanente Center for Health Research.
Mularski added that he was surprised that this many patients were receiving IV steroids. Patients in disaster with COPD are routinely treated with corticosteroids, bronchodilators and antibiotics. Although it's unentangled that steroids are effective in treating COPD exacerbations, it's less clarion which dose is preferable, stated the study authors.
The Massachusetts-based researchers looked at records on almost 80000 patients admitted with dreadful symptoms of COPD to 414 US hospitals in 2006 and 2007. All had been given steroids within the opening two days of their stay. The study did not count individuals who needed care in the intensive care unit. "These are patients that were sick enough to go into the hospital, but not indisposed enough to go into the ICU," said Dr Norman Edelman, chief medical officer of the American Lung Association.
Low-dose steroid pills seem to opus as well as exorbitant doses of injected steroids for patients hospitalized with unembroidered long-lived obstructive pulmonary disease (COPD), researchers report. Yet, some 90 percent of these COPD patients are given the higher doses, which is inimical to current prescribing guidelines, claims the swot appearing in the June 16 issue of the Journal of the American Medical Association. "We honestly think that doctors should be following hospital guidelines and treating patients with oral steroids, at least for those who are able to misappropriate oral steroids," said Dr Richard Mularski, author of an accompanying leader and a pulmonologist with Kaiser Permanente Center for Health Research.
Mularski added that he was surprised that this many patients were receiving IV steroids. Patients in disaster with COPD are routinely treated with corticosteroids, bronchodilators and antibiotics. Although it's unentangled that steroids are effective in treating COPD exacerbations, it's less clarion which dose is preferable, stated the study authors.
The Massachusetts-based researchers looked at records on almost 80000 patients admitted with dreadful symptoms of COPD to 414 US hospitals in 2006 and 2007. All had been given steroids within the opening two days of their stay. The study did not count individuals who needed care in the intensive care unit. "These are patients that were sick enough to go into the hospital, but not indisposed enough to go into the ICU," said Dr Norman Edelman, chief medical officer of the American Lung Association.
Device Resynchronization Therapy-Defibrillator Prolongs Life Of Patients With Heart Failure
Device Resynchronization Therapy-Defibrillator Prolongs Life Of Patients With Heart Failure.
Canadian researchers publish that an implantable ruse called a resynchronization therapy-defibrillator helps hold back the left side of the heart pumping properly, extending the life of heart neglect patients. Cardiac-resynchronization therapy, or CRT-D, also reduces heart failure symptoms, such as edema (swelling) and shortness of breath, as well as hospitalizations for some patients with middle to severe heart failure, the scientists added. "The sound idea of the therapy is to try to resynchronize the heart," said lead researcher Dr Anthony SL Tang, from the University of British Columbia in Vancouver.
It improves the heart's cleverness to become infected with and pump blood throughout the body. This study demonstrates that, in joining to symptom relief, the CRT-D extends life and keeps heart failure patients out of the hospital. Tang added that patients will be prolonged to need medical therapy and an implantable cardioverter-defibrillator (ICD) in adding to a CRT-D.
And "We are saying people who are receiving good medical therapy and are now wealthy to get a defibrillator, please go ahead and also do resynchronization therapy as well. This is worthwhile, because they will live longer and be more indubitably to stay out of the hospital". The report is published in the Nov 14, 2010 online copy of the New England Journal of Medicine, to coincide with a scheduled presentation of the findings Sunday at the American Heart Association annual caucus in Chicago.
Tang's team randomly assigned 1,798 patients with passive or moderate heart failure to have a CRT-D plus an ICD implanted or only an ICD implanted. Over 40 months of follow-up, the researchers found that those who received both devices accomplished a 29 percent reduction in their symptoms, compared with patients who did not experience the resynchronization device. In addition, there was a 27 percent reduction in deaths and feeling failure hospitalizations among those who also had a CRT-D, they found.
More than 22 million community worldwide, including 6 million patients in the United States, fall off from heart failure. These patients' hearts cannot adequately pump blood through the body. And although deaths from boldness disease have fallen over the last three decades, the death figure for heart failure is rising, the researchers said. Treating heart failure is also expensive, costing an estimated $40 billion each year in the United States alone.
In cardiac-resynchronization therapy, a stopwatch-sized mechanism is implanted in the more elevated chest to resynchronize the contractions of the heart's upper chambers, called ventricles. This is done by sending electrical impulses to the crux muscle. Resynchronizing the contractions of the ventricles can lend a hand the heart pump blood throughout the body more efficiently.
Canadian researchers publish that an implantable ruse called a resynchronization therapy-defibrillator helps hold back the left side of the heart pumping properly, extending the life of heart neglect patients. Cardiac-resynchronization therapy, or CRT-D, also reduces heart failure symptoms, such as edema (swelling) and shortness of breath, as well as hospitalizations for some patients with middle to severe heart failure, the scientists added. "The sound idea of the therapy is to try to resynchronize the heart," said lead researcher Dr Anthony SL Tang, from the University of British Columbia in Vancouver.
It improves the heart's cleverness to become infected with and pump blood throughout the body. This study demonstrates that, in joining to symptom relief, the CRT-D extends life and keeps heart failure patients out of the hospital. Tang added that patients will be prolonged to need medical therapy and an implantable cardioverter-defibrillator (ICD) in adding to a CRT-D.
And "We are saying people who are receiving good medical therapy and are now wealthy to get a defibrillator, please go ahead and also do resynchronization therapy as well. This is worthwhile, because they will live longer and be more indubitably to stay out of the hospital". The report is published in the Nov 14, 2010 online copy of the New England Journal of Medicine, to coincide with a scheduled presentation of the findings Sunday at the American Heart Association annual caucus in Chicago.
Tang's team randomly assigned 1,798 patients with passive or moderate heart failure to have a CRT-D plus an ICD implanted or only an ICD implanted. Over 40 months of follow-up, the researchers found that those who received both devices accomplished a 29 percent reduction in their symptoms, compared with patients who did not experience the resynchronization device. In addition, there was a 27 percent reduction in deaths and feeling failure hospitalizations among those who also had a CRT-D, they found.
More than 22 million community worldwide, including 6 million patients in the United States, fall off from heart failure. These patients' hearts cannot adequately pump blood through the body. And although deaths from boldness disease have fallen over the last three decades, the death figure for heart failure is rising, the researchers said. Treating heart failure is also expensive, costing an estimated $40 billion each year in the United States alone.
In cardiac-resynchronization therapy, a stopwatch-sized mechanism is implanted in the more elevated chest to resynchronize the contractions of the heart's upper chambers, called ventricles. This is done by sending electrical impulses to the crux muscle. Resynchronizing the contractions of the ventricles can lend a hand the heart pump blood throughout the body more efficiently.
Wednesday 17 April 2019
Positive Trends In The Treatment Of Leukemia And Lymphoma
Positive Trends In The Treatment Of Leukemia And Lymphoma.
Clinicians have made noteworthy advances in treating blood cancers with bone marrow and blood stem-post apartment transplants in recent years, significantly reducing the risk of treatment-related complications and death, a green study shows. Between the early 1990s and 2007, there was a 41 percent drop in the overall jeopardy of death in an analysis of more than 2,500 patients treated at Fred Hutchinson Cancer Center in Seattle, a chairwoman in the field of blood cancers and other malignancies. Researchers from the Fred Hutchinson Cancer Center, who conducted the study, also notable dramatic decreases in treatment complications such as infection and organ damage.
The consider was published in the Nov 24, 2010 issue of the New England Journal of Medicine. "We have made gross strides in understanding this very complex procedure and have yielded quite spectacular results," said contemplate senior author Dr George McDonald, a gastroenterologist with Hutchinson and a professor of medication at the University of Washington, in Seattle. "This is one of the most complex procedures in medicine and we apprehend a lot of complications we didn't before".
Dr Mitchell Smith, head of the lymphoma service at Fox Chase Cancer Center in Philadelphia, feels the extended positive trend - if not the exact numbers - can be extrapolated to other concern centers. "Most of the things that they've been doing have been generally adopted by most uproot units, although you do have to be careful because they get a select patient population and they are experts. The smaller centers that don't do as many procedures may not get the compel same results, but the trend is clearly better".
Treatment of high-risk blood cancers such as leukemia, lymphoma and myeloma was revolutionized in the 1970s with the introduction of allogeneic blood or bone marrow transplantation. Before this advance, patients with blood cancers had far more restrictive options. The high-dose chemotherapy or emanation treatments designed to wreak blood cancer cells (which divide faster than everyday cells) often damaged or destroyed the patient's bone marrow, leaving it unable to produce the blood cells needed to gain oxygen, fight infection and stop bleeding.
Transplanting healthy stem cells from a provider into the patient's bone marrow - if all went well - restored its power to produce these vital blood cells. While the treatment met with great success, it also had a lot of serious side effects, including infections, device damage and graft-versus-host disease (GVHD), which were severe enough to prevent older and frailer patients from undergoing the procedure. But the days of old 40 years has seen a lot of improvements in managing these problems.
Clinicians have made noteworthy advances in treating blood cancers with bone marrow and blood stem-post apartment transplants in recent years, significantly reducing the risk of treatment-related complications and death, a green study shows. Between the early 1990s and 2007, there was a 41 percent drop in the overall jeopardy of death in an analysis of more than 2,500 patients treated at Fred Hutchinson Cancer Center in Seattle, a chairwoman in the field of blood cancers and other malignancies. Researchers from the Fred Hutchinson Cancer Center, who conducted the study, also notable dramatic decreases in treatment complications such as infection and organ damage.
The consider was published in the Nov 24, 2010 issue of the New England Journal of Medicine. "We have made gross strides in understanding this very complex procedure and have yielded quite spectacular results," said contemplate senior author Dr George McDonald, a gastroenterologist with Hutchinson and a professor of medication at the University of Washington, in Seattle. "This is one of the most complex procedures in medicine and we apprehend a lot of complications we didn't before".
Dr Mitchell Smith, head of the lymphoma service at Fox Chase Cancer Center in Philadelphia, feels the extended positive trend - if not the exact numbers - can be extrapolated to other concern centers. "Most of the things that they've been doing have been generally adopted by most uproot units, although you do have to be careful because they get a select patient population and they are experts. The smaller centers that don't do as many procedures may not get the compel same results, but the trend is clearly better".
Treatment of high-risk blood cancers such as leukemia, lymphoma and myeloma was revolutionized in the 1970s with the introduction of allogeneic blood or bone marrow transplantation. Before this advance, patients with blood cancers had far more restrictive options. The high-dose chemotherapy or emanation treatments designed to wreak blood cancer cells (which divide faster than everyday cells) often damaged or destroyed the patient's bone marrow, leaving it unable to produce the blood cells needed to gain oxygen, fight infection and stop bleeding.
Transplanting healthy stem cells from a provider into the patient's bone marrow - if all went well - restored its power to produce these vital blood cells. While the treatment met with great success, it also had a lot of serious side effects, including infections, device damage and graft-versus-host disease (GVHD), which were severe enough to prevent older and frailer patients from undergoing the procedure. But the days of old 40 years has seen a lot of improvements in managing these problems.
Subscribe to:
Posts (Atom)